These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27352629)

  • 1. The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany.
    Jacob L; Hadji P; Kostev K
    Climacteric; 2016 Oct; 19(5):478-81. PubMed ID: 27352629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice.
    McGowan B; Bennett K; Barry M
    Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):763-9. PubMed ID: 20582909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
    Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
    Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
    Targownik LE; Lix LM; Leung S; Leslie WD
    Gastroenterology; 2010 Mar; 138(3):896-904. PubMed ID: 19931262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
    Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
    J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
    Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors use and change in bone mineral density.
    Arj A; Razavi Zade M; Yavari M; Akbari H; Zamani B; Asemi Z
    Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between gastrointestinal events and osteoporosis treatment initiation in women diagnosed with osteoporosis in France: a retrospective analysis.
    Cortet B; Modi A; Tang J; Fan CP; Sajjan S; Weaver JP
    BMC Musculoskelet Disord; 2016 Apr; 17():195. PubMed ID: 27139225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
    Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
    Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and the risk of colorectal cancer.
    van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
    Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between osteoporosis and coronary artery disease in postmenopausal women.
    Lee SN; Cho JY; Eun YM; Song SW; Moon KW
    Climacteric; 2016 Oct; 19(5):458-62. PubMed ID: 27397609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.